Genmab — Februar 2023
-
Når DSV kan nedjustere resultatet med over 30%, og alligevel få aktien til at buldre i vejret, kan Genmab vel også klare sig
-
USA/lukning: Wall Street endte i rødt efter jobchok trods Apple-plus https://www.proinvestor.com/investornyt/936305/usa-lukning-wall-street-endte-i-rodt-efter-jobchok-trods-apple-plus
-
Shortpositioner i danske aktier https://www.proinvestor.com/boards/110133
-
Top 10 most anticipated drug launches of 2023 https://www.fiercepharma.com/marketing/top-10-most-anticipated-drug-launches-2023?itm_source=parsely-api
-
Mim8 poster abstracts at Congress of European Association for Haemophilia and Allied Disorders 2023 PO072 and PO124 https://onlinelibrary.wiley.com/doi/10.1111/hae.14715
-
-
Ser ud til de 50% fibonacci retracement ned til 2595 holde. Ugekort indikere bundvending. https://www.proinvestor.com/boards/107738/$/110193
-
Godmorgen
-
Dagens mange regnskaber: https://www.proinvestor.com/finanskalender
-
AbbVie puts bigger M&A back on the table. https://www.fiercepharma.com/pharma/abbvie-teases-future-ma-deals-worth-more-2-billion-wsj
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind